▽Drug Injury Watch ●04/04 01:23 Going deeper into the full-text of this semaglutide-NAION medical study article, we point out the time relationship between Ozempic and Rybelsus use dates by patients with type 2 diabetes and the diagnosis dates for their NAION. From the Results section of that March 2025 JAMA Ophthalmology article, a part titled "Risk of NAION in Terms of Follow-Up Duration After Semaglutide Prescription" sets fo
▽Office of Research Integrity ●03/20 07:31 Mar19Research Misconduct Finding: Liping ZhangORI found that Liping Zhang, PhD, former Assistant Professor in the Department of Medicine, Section of Nephrology, BCM, engaged in research misconduct under 42 C.F.R. Part 93 in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of H
▽Pharmafocus.com Newsfeed ●03/16 02:40 ProductLife Group acquires HERAX Life Science to boost R&D and IT capabilitiesBusiness and technology consultancy HERAX Life Science has been acquired by ProductLife Group (PLG).Solventum’s purification and filtration business sold to Thermo Fisher Scientific for $4.1bn3M spin-off Solventum has announced that global supplier of analytical instruments Thermo Fisher Scientific has agreed to purch
